P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-45 years with intermediate and poor-risk metastatic germ cell tumours (GCTs) Meeting Abstract
| Authors: | Mak, B.; Tran, B.; Pashankar, F. D.; Mazhar, D.; Huddart, R. A.; Wheater, M.; Walpole, E. T.; Feldman, D. R.; Dunwoodie, E.; Lawrence, N. J.; Birtle, A. J.; Wyld, D.; Stevanovic, A. G.; Balagtas, J. M. S.; Stockler, M. R.; Davis, I. D.; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) |
| Abstract Title: | P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-45 years with intermediate and poor-risk metastatic germ cell tumours (GCTs) |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900378 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.TPS524 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS524 -- Source: Wos |
